Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?
about
Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cellsNew drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseasesBDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortexGender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosisImpaired nerve growth factor homeostasis in patients with bipolar disorder.Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model.Methyl 3,4-dihydroxybenzoate promotes neurite outgrowth of cortical neurons cultured in vitroNGF in Early Embryogenesis, Differentiation, and Pathology in the Nervous and Immune Systems.Cord blood immune biomarkers in small for gestational age birthsRecent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosisSerum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa.Brain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomesThe role of adenosine in Alzheimer's diseaseTriggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotectionApoptosis and in vitro Alzheimer disease neuronal models.Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems.Tuning and fine-tuning of synapses with adenosine.Opportunities and challenges in developing Alzheimer disease therapeutics.Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain.Nanoparticles based stem cell tracking in regenerative medicine.New strategies in the management of Guillain-Barré syndrome.Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review.The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension.Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.Genotoxicity profile of erinacine A-enriched Hericium erinaceus myceliumUpregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.Delivery of brain-derived neurotrophic factor via nose-to-brain pathway.Implications of white matter damage in amyotrophic lateral sclerosis (Review).Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors.Blockade of p75 Neurotrophin Receptor Reverses Irritability and Anxiety-Related Behaviors in a Rat Model of Status EpilepticusPeripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders?Decreased levels of brain-derived neurotrophic factor in the remitted state of unipolar depressive disorder.Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal.Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology.The impact of neurotrophin-3 on the dorsal root transitional zone following injury.Heparin-Poloxamer Thermosensitive Hydrogel Loaded with bFGF and NGF Enhances Peripheral Nerve Regeneration in Diabetic Rats.
P2860
Q21263029-1979C46D-0D58-421F-AFF7-D69ADF572590Q26866194-CAEDBB18-9CD5-46CD-8E14-119A8CCB88ADQ30497055-0F351333-061E-476D-8983-06E29C80BDC4Q34138065-46FD2D73-2565-4ABE-84F5-6F5A0D6725E4Q34141881-28DF4C0E-BAED-413B-924F-14937BD534CAQ34639384-15968DCE-B8F5-4DF4-9854-F988E89EEC43Q35123777-0F8F99DB-46D7-4A5F-BFB8-B0578067CDF3Q35875769-3C33DB44-D508-4FA6-B86E-8A23F644417AQ35991781-82FD6F7B-6C6A-489C-A220-A6D069E86A82Q36117618-D4BFD4D6-D913-48C3-B040-CB54E1497B36Q36503572-49C0E4D7-106B-48A4-8E26-0F0FA13389FCQ37242731-046F282C-010E-4436-9BDD-B368301200D0Q37328165-A74A1C37-08BD-4C40-8176-84415F7814E7Q37402673-51F4BD32-9144-42BD-A94D-EB5EE91ECC52Q37512421-C1AB2FE8-2D6C-4C7A-A08F-86F6A9E349F1Q37513632-F212AAC0-D296-46C9-A4AE-5B3AEC46D15FQ37602133-B89B6103-85AA-412D-96C1-3835A91F33B7Q37700201-5FEADBDA-EB8E-4AE2-B282-7D1118112D77Q37940825-505E9B66-BB00-447B-B93E-6403D2195409Q38046005-D95738E7-7BAB-4102-8873-4F03A9F0A44FQ38129058-90161B14-2D56-4E2D-8F61-3E1339B58BD1Q38140727-1AE0F0D0-A711-44DF-A453-0B8C9327F16EQ38263540-E452EB51-B677-4B3D-A5D8-4AF8D078AC70Q38711637-14513CF7-8E7D-4DC2-A3A2-C070A51AA817Q39083326-5CB72CCE-9909-4C62-B3E8-5F7521747FF6Q41680849-BED521C8-3479-4F02-9119-8943D2335E16Q42380866-EB171BB7-F966-4F14-B194-897CFB13313DQ42380871-A0AEA956-D8BD-4B48-AAE7-72E7C8DF8D7FQ42658376-F1493478-2830-4FAB-A9D0-87077603B5DBQ42711976-C7EB5368-BA2C-47F3-AC58-50179BFB7A50Q47717547-B87EECD5-D951-41E2-A2E2-A47E45908446Q48385064-BAFAF9C1-1AD3-4E79-80D6-1440BB6A2EE2Q48682738-EE879918-294C-4819-B38F-6735AFB9F693Q48945798-89566B25-5753-4631-827E-614CEAB18388Q49015193-3EA74DAD-935C-4702-8DA3-D3A04836A1D3Q51875231-F68A29C2-AD5B-4C7E-8DD7-9AD1FAE3D64CQ52587389-C9415B0A-2753-4E4E-BFAF-A0CD638D04C6Q54981413-4CFD9EEE-860A-4F09-BD7A-F875CC22C498
P2860
Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neurotrophic factors--a tool f ...... d neuroimmunological diseases?
@en
type
label
Neurotrophic factors--a tool f ...... d neuroimmunological diseases?
@en
prefLabel
Neurotrophic factors--a tool f ...... d neuroimmunological diseases?
@en
P2093
P1476
Neurotrophic factors--a tool f ...... d neuroimmunological diseases?
@en
P2093
Jockers-Scherübl MC
Rochlitzer S
Schulte-Herbrüggen O
P304
P356
10.2174/092986707781745578
P577
2007-01-01T00:00:00Z